Immunoassay News and Research RSS Feed - Immunoassay News and Research

Canada funds 22 inventive ideas for improving health in low-resource countries

Canada funds 22 inventive ideas for improving health in low-resource countries

Grand Challenges Canada, funded by the Government of Canada, today announced $2.4 million in seed funds shared between 22 projects from Canada and nine developing nations, to pursue inventive new ideas for improving health in low-resource countries. [More]
SeraCare Life Sciences announces launch of new ACCURUN 501 C. difficile Control

SeraCare Life Sciences announces launch of new ACCURUN 501 C. difficile Control

SeraCare Life Sciences, a provider of high-quality biological materials that help optimize diagnostic performance, reliability and repeatability across the IVD lifecycle, today announced the launch of its new ACCURUN 501 C. difficile Control – the company's first molecular control product targeting hospital acquired infections. [More]
Bio-Techne revenue increases 16% to $92.5 million in fourth quarter 2014

Bio-Techne revenue increases 16% to $92.5 million in fourth quarter 2014

Techne Corporation, (d/b/a Bio-Techne) today reported its financial results for the fourth quarter and full year ended June 30, 2014. [More]
Alere announces financial results for quarter ended 2014

Alere announces financial results for quarter ended 2014

Alere Inc., a global leader in rapid diagnostics and health information solutions, today announced its financial results for the quarter ended June 30, 2014. [More]
Beckman ranks among industry's highest performing Service providers in clinical diagnostics

Beckman ranks among industry's highest performing Service providers in clinical diagnostics

Committed to providing the solutions labs need to meet the challenges they face, Beckman Coulter Diagnostics has been ranked among the industry's highest performing Service providers in the clinical diagnostics industry in the 2014 IMV ServiceTrak Executive Summary Report. [More]
Addcare’s liquid handling systems, automated immunoassay workstations, customized systems

Addcare’s liquid handling systems, automated immunoassay workstations, customized systems

Addcare Bio-Tech Co., Ltd. provides advanced liquid handling systems, automated immunoassay workstations and customized systems. [More]
Chemclin's Anti-TB assay helps in qualitative determination of Anti-TB in human serum

Chemclin's Anti-TB assay helps in qualitative determination of Anti-TB in human serum

Chemclin's Anti-TB assay provides components for in-vitro qualitative determination of Antibody to Mycobacterium Tuberculosis (Anti-TB) in human serum or plasma by an indirect chemiluminescent assay method. [More]
Randox's Acusera Immunoassay Speciality 1 quality control receives FDA clearance

Randox's Acusera Immunoassay Speciality 1 quality control receives FDA clearance

In Q3 of 2013, Randox announced that the Food and Drug Administration has approved the company's Acusera Immunoassay Speciality 1 quality control for use in US laboratories. [More]
Beckman announces national availability of Prostate Health Index

Beckman announces national availability of Prostate Health Index

Beckman Coulter Diagnostics, a global leader in prostate cancer diagnostics, announces national availability of the Prostate Health Index (phi)*, a simple, non‐invasive blood test that is three times more specific in detecting prostate cancer1 than PSA (prostate‐specific antigen). [More]
Novel device uses smartphone to measure cortisol concentration in saliva

Novel device uses smartphone to measure cortisol concentration in saliva

Researchers have developed a device that uses any smartphone to measure the cortisol concentration in saliva. The device was presented Tuesday, June 24, at ICE/ENDO 2014, the joint meeting of the International Society of Endocrinology and the Endocrine Society in Chicago. [More]
Ferring Pharmaceuticals, Roche partner to make personalised infertility treatment possible

Ferring Pharmaceuticals, Roche partner to make personalised infertility treatment possible

Ferring Pharmaceuticals and Roche have announced a collaboration to combine diagnostic testing technology from Roche with Ferring's human cell line derived recombinant follicle-stimulating hormone (human rFSH), a gonadotrophin currently in phase III development. [More]
Newborn congenital adrenal hyperplasia screening justified

Newborn congenital adrenal hyperplasia screening justified

The Swedish neonatal screening programme successfully detected all cases of clinically classified salt-wasting congenital adrenal hyperplasia during a 26-year period, researchers report. [More]
Comprehensive analysis of global markets for immunoassay technologies

Comprehensive analysis of global markets for immunoassay technologies

Reportbuyer.com has added a new market research report: Immunoassays: Technologies and Global Markets [More]
Beckman Coulter to feature scientific data on the VERIS MDx System at ECCMID 2014

Beckman Coulter to feature scientific data on the VERIS MDx System at ECCMID 2014

As part Beckman Coulter’s commitment to advancing the field of molecular diagnostics the company will feature scientific data on the VERIS MDx System at the 2014 European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) to be held on 10‐13 May in Barcelona, Spain. Researchers will present five studies on the VERIS system and the company will offer an educational symposium addressing issues in viral load monitoring. The VERIS MDx System and VERIS human Cytomegalovirus (CMV) Assay received CE Marks earlier this year. [More]
VERIS MDx System from Beckman Coulter obtains CE Mark

VERIS MDx System from Beckman Coulter obtains CE Mark

Beckman Coulter Diagnostics has obtained CE Mark for the VERIS MDx System* and VERIS human Cytomegalovirus (CMV) assay*. Attaining CE Mark on the VERIS MDx System and the VERIS CMV assay are key milestones in the expansion of Beckman Coulter’s presence in molecular diagnostics. [More]

Bio-Techne makes $10M equity investment in CyVek

Techne Corporation, d/b/a Bio-Techne, announced today that it has made a $10 million equity investment in CyVek, Inc. (CyVek), with a commitment to acquire CyVek if certain future milestones are met. [More]

American Bio Medica's net sales decrease 7.3% in fourth quarter 2013

American Bio Medica Corporation today announced financial results for the fourth quarter and year ended December 31, 2013. [More]
Singulex signs agreement to co-develop the Sgx Clarity system with Tecan

Singulex signs agreement to co-develop the Sgx Clarity system with Tecan

Singulex, Inc., the developer and leading provider of Single Molecule Counting (SMC) technology for clinical diagnostics and scientific discovery, today announced an agreement to co-develop the Sgx Clarity system with Tecan, a leading global provider of laboratory automation instruments. [More]
Mindray's net revenues increase 16.5% to $368.4 million in fourth quarter 2013

Mindray's net revenues increase 16.5% to $368.4 million in fourth quarter 2013

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2013. [More]
New biomarker for stress in wild animals facing global climate change

New biomarker for stress in wild animals facing global climate change

Chemical analyses by neuroscientist Jerrold Meyer and colleagues at the University of Massachusetts Amherst are helping to establish hair cortisol concentration (HCC) as an important new biomarker for stress in wild animals facing global climate change. [More]